FDA
approval
· 2020-09-28
FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for norepinephrine bitartrate from Meitheal Pharmaceuticals Inc. to market this generic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NOREPINEPHRINE BITARTRATE (NOREPINEPHRINE BITARTRATE)